Matching-Adjusted Indirect Comparison (MAIC): Entrectinib versus Crizotinib in Asian Patients with ROS1+NSCLC

被引：0
|
作者：
Lu, S. [1 ]
Fan, Y. [2 ]
Yu, Y. [3 ]
Dong, X. [4 ]
Li, J. [5 ]
Zhao, J. [6 ]
Tao, S. [7 ]
Chen, M. [7 ]
Chen, Y. [7 ]
Liu, Y. [7 ]
Xu, J. [7 ]
Hu, X. [8 ]
机构：
[1] Shanghai Jiao Tong Univ, Shanghai Chest Hosp, Shanghai, Peoples R China
[2] Zhejiang Canc Hosp, Hangzhou, Peoples R China
[3] Dept Med Oncol, Harbin, Peoples R China
[4] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Wuhan, Peoples R China
[5] Sichuan Canc Hosp, Chengdu, Peoples R China
[6] Peking Univ Canc Hosp & Inst, Beijing, Peoples R China
[7] Shanghai Roche Pharmaceut Ltd, Shanghai, Peoples R China
[8] Fudan Univ, Shanghai Canc Ctr, Shanghai, Peoples R China
来源：
JOURNAL OF THORACIC ONCOLOGY | 2023年 / 18卷 / 11期
关键词：
ROS1+NSCLC; Asian patients; Matching-Adjusted Indirect Comparison;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
EP12.02-12
引用
收藏
页码：S679 / S679
页数：1
相关论文
共 50 条
  • [41] Efficacy of transarterial radioembolization using Y-90 resin microspheres versus atezolizumab-bevacizumab in unresectable hepatocellular carcinoma: A matching-adjusted indirect comparison
    Agirrezabal, Ion
    Bouattour, Mohamed
    Pinato, David J.
    D'Alessio, Antonio
    Brennan, Victoria K.
    Carion, Phuong Lien
    Shergill, Suki
    Amoury, Nathalie
    Vilgrain, Valerie
    EUROPEAN JOURNAL OF CANCER, 2024, 196
  • [42] Matching-Adjusted Indirect Comparison of Crisaborole Ointment 2% vs. Topical Calcineurin Inhibitors in the Treatment of Patients with Mild-to-Moderate Atopic Dermatitis
    Thom, Howard
    Cheng, Vincent
    Keeney, Edna
    Neary, Maureen P.
    Eccleston, Anthony
    Zang, Chuanbo
    Cappelleri, Joseph C.
    Cha, Amy
    Thyssen, Jacob P.
    DERMATOLOGY AND THERAPY, 2022, 12 (01) : 185 - 194
  • [43] Matching-Adjusted Indirect Comparison of Crisaborole Ointment 2% vs. Topical Calcineurin Inhibitors in the Treatment of Patients with Mild-to-Moderate Atopic Dermatitis
    Howard Thom
    Vincent Cheng
    Edna Keeney
    Maureen P. Neary
    Anthony Eccleston
    Chuanbo Zang
    Joseph C. Cappelleri
    Amy Cha
    Jacob P. Thyssen
    Dermatology and Therapy, 2022, 12 : 185 - 194
  • [44] Matching-Adjusted Indirect Comparison of Efficacy and Consumption of rVIII-SingleChain Versus Two Recombinant FVIII Products Used for Prophylactic Treatment of Adults/Adolescents with Severe Haemophilia A
    Bonanad, Santiago
    Nunez, Ramiro
    Luis Poveda, Jose
    Kurnik, Karin
    Goldmann, Georg
    Andreozzi, Valeska
    Vandewalle, Bjorn
    Santos, Sandra
    ADVANCES IN THERAPY, 2021, 38 (09) : 4872 - 4884
  • [45] Matching-Adjusted Indirect Comparison of Efficacy and Consumption of rVIII-SingleChain Versus Two Recombinant FVIII Products Used for Prophylactic Treatment of Adults/Adolescents with Severe Haemophilia A
    Santiago Bonanad
    Ramiro Núñez
    Jose Luis Poveda
    Karin Kurnik
    Georg Goldmann
    Valeska Andreozzi
    Björn Vandewalle
    Sandra Santos
    Advances in Therapy, 2021, 38 : 4872 - 4884
  • [46] An anchored matching-adjusted indirect comparison of fixed-dose combination calcipotriol and betamethasone dipropionate (Cal/BDP) cream versus Cal/BDP foam for the treatment of psoriasis
    Bewley, Anthony
    Barker, Erin
    Baker, Hannah
    Green, Will
    Avey, Brooke
    Pi-Blanque, Aina
    Galvan, Jordi
    Trebbien, Paw
    Praestegaard, Morten
    JOURNAL OF DERMATOLOGICAL TREATMENT, 2022, 33 (08) : 3191 - 3198
  • [47] A matching-adjusted indirect treatment comparison (MAIC) of daratumumab-bortezomib-melphalan-prednisone (D-VMP) versus lenalidomide-dexamethasone continuous (Rd continuous), lenalidomide-dexamethasone 18 months (Rd 18), and melphalan-prednisone-thalidomide (MPT)
    Dimopoulos, Meletios A.
    Cavo, Michele
    Mateos, Maria-Victoria
    Facon, Thierry
    Heeg, Bart
    van Beekhuizen, Sophie
    Gebregergish, Samron B.
    Nair, Sandhya
    Pisini, Marta
    Lam, Annette
    Slavcev, Mary
    LEUKEMIA & LYMPHOMA, 2020, 61 (03) : 714 - 720
  • [48] Matching-Adjusted Indirect Comparison of Health-Related Quality of Life and Adverse Events of Apalutamide Versus Enzalutamide in Non-Metastatic Castration-Resistant Prostate Cancer
    Chowdhury, Simon
    Oudard, Stephane
    Uemura, Hiroji
    Joniau, Steven
    Pilon, Dominic
    Lefebvre, Patrick
    McQuarrie, Kelly
    Liu, Jinan
    Dearden, Lindsay
    Sermon, Jan
    Van Sanden, Suzy
    Diels, Joris
    Hadaschik, Boris A.
    ADVANCES IN THERAPY, 2020, 37 (01) : 512 - 526
  • [49] Matching-Adjusted Indirect Comparison of Health-Related Quality of Life and Adverse Events of Apalutamide Versus Enzalutamide in Non-Metastatic Castration-Resistant Prostate Cancer
    Simon Chowdhury
    Stéphane Oudard
    Hiroji Uemura
    Steven Joniau
    Dominic Pilon
    Patrick Lefebvre
    Kelly McQuarrie
    Jinan Liu
    Lindsay Dearden
    Jan Sermon
    Suzy Van Sanden
    Joris Diels
    Boris A. Hadaschik
    Advances in Therapy, 2020, 37 : 512 - 526
  • [50] Letter to the Editor Regarding 'Matching-Adjusted Indirect Comparison of the Long-Term Efficacy Maintenance and Adverse Event Rates of Lebrikizumab Versus Dupilumab in Moderate-to-Severe Atopic Dermatitis'
    Bastian, Mike
    Freemantle, Nick
    Rossi, Ana B.
    Shumel, Brad
    Le Bagousse, Gaelle Bego
    Wang, Zhixiao
    Xu, Yingxin
    Guyot, Patricia
    DERMATOLOGY AND THERAPY, 2024, 14 (03) : 819 - 821
12345